The source of LAM cells remains unknown; however, LAM lesions have been reported in the uterus [16, 17], and TSC2 gene mutations have been observed in the uterus and lungs of patients with S-LAM [18]. This evidence concerns the gene TSC2 and lymphangioleiomyomatosis.